Colony Group’s Globus Medical GMED Stock Holding History

Colony Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,100	Closed	-$391K	–	824
2021 Q3	$391K	Buy	+5,100	New	+$409K	0.01%	623

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Colony Group's GMED Position: Q4 2021 in Review

Colony Group sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 5,100 shares — an estimated $391K sold.

Colony Group first reported a position in GMED in Q3 2021 and held it in 1 quarter. The position peaked at $391K in Q3 2021. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

Colony Group reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
Colony Group sold 5,100 Globus Medical shares in Q4 2021, an estimated $391K.
Colony Group first reported a position in Globus Medical in Q3 2021 and held it in 1 quarter.
Colony Group's Globus Medical position peaked at $391K in Q3 2021.
373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on Colony Group's 13F filing for Q4 2021, filed 15 Feb 2022.